Traditional Chinese medicine composition for treating Qi-stagnation and blood stasis type hepatorenal syndrome

Abstract

The invention belongs to the technical field of medicine, and particularly relates to a traditional Chinese medicine composition for treating a Qi-stagnation and blood stasis type hepatorenal syndrome. The traditional Chinese medicine composition is prepared from, by weight, 4-8 parts of whitewood, 4-8 parts of Sterculia nobilis shells, 4-8 parts of the seeds of Lathyrus davidii, 4-8 parts of the fruits of Manglietia yuyuanensis, 4-8 parts of dysosma versipellis, 4-8 parts of the root of Undulateleaf Aralia, 4-8 parts of Akebia trifoliate, 4-8 parts of Orchidaceae Pecteilis, 4-8 parts of phoenix hawksbeard roots, 4-8 parts of semen sesami nigrum and 4-8 parts of licorice roots. All the medicinal materials are combined to achieve the effects of soothing the liver, promoting the circulation of qi, promoting blood circulation to remove blood stasis and tonifying the liver and kidney. The clinical symptoms and physical signs of the patient can be effectively relieved, the level of blood urea nitrogen, creatinine and urine protein can be lowered, the glomerular filtration rate can be improved, the kidney function can be improved, the glutamic-pyruvic transaminase and glutamic oxalacetic transaminase level can be lowered, and the liver function can be improved.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a traditional Chinese medicine composition for treating hepatorenal syndrome of qi stagnation and blood stasis type. Background technique [0002] Hepatorenal syndrome (HRS) refers to a functional renal failure in patients with severe liver diseases such as cirrhosis and severe viral hepatitis without clear primary renal disease. It was first proposed by Helwig in 1932. At that time, it was used to describe acute renal failure after biliary obstruction surgery. Later, it was used to refer to all diseases involving the liver and kidney at the same time. At present, it often refers to liver cirrhosis, fulminant hepatic failure, severe viral hepatitis, primary Functional renal failure secondary to severe liver disease such as primary or secondary liver cancer. There are no primary and specific organic lesions in the kidneys of patients with hepatorenal syndrome, and th...

AI Technical Summary

Problems solved by technology

At present, the pathogenesis of hepatorenal syndrome is not fully understood by Western medicine, and there is no effective treatment for it.